These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 29562593)
21. Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Bataille P; Achard JM; Fournier A; Boudailliez B; Westeel PF; el Esper N; Bergot C; Jans I; Lalau JD; Petit J Kidney Int; 1991 Jun; 39(6):1193-205. PubMed ID: 1895673 [TBL] [Abstract][Full Text] [Related]
22. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Bushinsky DA; Parker WR; Asplin JR Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032 [TBL] [Abstract][Full Text] [Related]
23. Intestinal Calcium Absorption among Hypercalciuric Patients with or without Calcium Kidney Stones. Vezzoli G; Macrina L; Rubinacci A; Spotti D; Arcidiacono T Clin J Am Soc Nephrol; 2016 Aug; 11(8):1450-1455. PubMed ID: 27284011 [TBL] [Abstract][Full Text] [Related]
24. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Gallagher JC; Sai A; Templin T; Smith L Ann Intern Med; 2012 Mar; 156(6):425-37. PubMed ID: 22431675 [TBL] [Abstract][Full Text] [Related]
25. The Prevalence of Vitamin D Deficiency, Its Predisposing Factors and Association with 24-hour Urine Metabolites Among Iranian Kidney Stone Formers. Tavasoli S; Taheri F; Bagheri Amiri F; Borumandnia N; Basiri A; Parvin M; Taheri M Iran J Kidney Dis; 2021 Jul; 15(4):263-269. PubMed ID: 34278997 [TBL] [Abstract][Full Text] [Related]
26. Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet. Frick KK; Asplin JR; Culbertson CD; Granja I; Krieger NS; Bushinsky DA Am J Physiol Renal Physiol; 2014 May; 306(9):F1081-7. PubMed ID: 24573387 [TBL] [Abstract][Full Text] [Related]
27. Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women. Gallagher JC; Smith LM; Yalamanchili V Menopause; 2014 Nov; 21(11):1173-80. PubMed ID: 24937025 [TBL] [Abstract][Full Text] [Related]
28. Effect of Vitamin D Treatment on Dynamics of Stones Formation in the Urinary Tract and Bone Density in Children with Idiopathic Hypercalciuria. Milart J; Lewicka A; Jobs K; Wawrzyniak A; Majder-Łopatka M; Kalicki B Nutrients; 2020 Aug; 12(9):. PubMed ID: 32825353 [TBL] [Abstract][Full Text] [Related]
29. Possible link between vitamin D and hyperoxaluria in patients with renal stone disease. Giannini S; Nobile M; Castrignano R; Pati T; Tasca A; Villi G; Pellegrini F; D'Angelo A Clin Sci (Lond); 1993 Jan; 84(1):51-4. PubMed ID: 8382134 [TBL] [Abstract][Full Text] [Related]
30. A pilot study of the effect of sodium thiosulfate on urinary lithogenicity and associated metabolic acid load in non-stone formers and stone formers with hypercalciuria. Okonkwo OW; Batwara R; Granja I; Asplin JR; Goldfarb DS PLoS One; 2013; 8(4):e60380. PubMed ID: 23593205 [TBL] [Abstract][Full Text] [Related]
32. [Alterations in bone mineral metabolism in patients with calcium kidney stone disease and polymorphism of vitamin D receptor. Preliminary results]. Moyano MJ; Gómez de Tejada MJ; García Lozano R; Moruno R; Ortega R; Martí V; Sánchez Palencia R; Miranda MJ; Palma A; Pérez Cano R Nefrologia; 2007; 27(6):694-703. PubMed ID: 18336098 [TBL] [Abstract][Full Text] [Related]
33. Calcium and vitamin D have a synergistic role in a rat model of kidney stone disease. Letavernier E; Verrier C; Goussard F; Perez J; Huguet L; Haymann JP; Baud L; Bazin D; Daudon M Kidney Int; 2016 Oct; 90(4):809-17. PubMed ID: 27475231 [TBL] [Abstract][Full Text] [Related]
34. Vascular calcification and bone mineral density in recurrent kidney stone formers. Shavit L; Girfoglio D; Vijay V; Goldsmith D; Ferraro PM; Moochhala SH; Unwin R Clin J Am Soc Nephrol; 2015 Feb; 10(2):278-85. PubMed ID: 25635036 [TBL] [Abstract][Full Text] [Related]
35. Metabolic effects of cholecalciferol supplementation in patients with calcium nephrolithiasis and vitamin D deficiency. Vitale C; Marangella M; Bermond F; Fabbrini L; Tricerri A World J Urol; 2021 Feb; 39(2):597-603. PubMed ID: 32367158 [TBL] [Abstract][Full Text] [Related]
36. A 250 μg/week dose of vitamin D was as effective as a 50 μg/d dose in healthy adults, but a regimen of four weekly followed by monthly doses of 1250 μg raised the risk of hypercalciuria. Zwart SR; Parsons H; Kimlin M; Innis SM; Locke JP; Smith SM Br J Nutr; 2013 Nov; 110(10):1866-72. PubMed ID: 23595003 [TBL] [Abstract][Full Text] [Related]
37. Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Prié D; Ravery V; Boccon-Gibod L; Friedlander G Kidney Int; 2001 Jul; 60(1):272-6. PubMed ID: 11422761 [TBL] [Abstract][Full Text] [Related]
39. Safety of calcium and vitamin D supplements, a randomized controlled trial. Aloia JF; Katumuluwa S; Stolberg A; Usera G; Mikhail M; Hoofnagle AN; Islam S Clin Endocrinol (Oxf); 2018 Dec; 89(6):742-749. PubMed ID: 30180273 [TBL] [Abstract][Full Text] [Related]
40. Effect of vitamin D supplementation on 24-hour urine calcium in patients with calcium Urolithiasis and vitamin D deficiency. Taheri M; Tavasoli S; Shokrzadeh F; Amiri FB; Basiri A Int Braz J Urol; 2019; 45(2):340-346. PubMed ID: 30735332 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]